FLAG Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2M

  • Investors
  • 1

FLAG Therapeutics General Information

Description

Operator of an oncology company intended to develop a dual-acting small molecule for the treatment of Glioblastoma. The company focuses on developing new small-molecule therapeutics for difficult-to-treat cancer and its therapies are based on two investigational product platforms that are Anti-angiogenic, Anti-tubulin and the Folate-target Anti-cancer (FTAC) that includes multiple water-soluble small molecule compounds, enabling doctors to treat multiple cancer types, including brain, lung, ovarian and pancreatic.

Contact Information

Website
www.flagtherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9168 Wooden Road
  • Raleigh, NC 27617
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 9168 Wooden Road
  • Raleigh, NC 27617
  • United States
+1 (919)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FLAG Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 01-Jul-2019 $2M Completed Pre-Clinical Trials
4. Seed Round 09-Jan-2019 Completed Startup
3. Debt - General 21-Nov-2018 Completed Startup
2. Grant 01-Jan-2017 $1.5M $250K Completed Startup
1. Debt - General 06-Mar-2015 $250K $250K Completed Startup
To view FLAG Therapeutics’s complete valuation and funding history, request access »

FLAG Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view FLAG Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

FLAG Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an oncology company intended to develop a dual-acting small molecule for the treatment of Glioblastoma. The
Drug Discovery
Raleigh, NC
5 As of 2024

South San Francisco, CA
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FLAG Therapeutics Competitors (2)

One of FLAG Therapeutics’s 2 competitors is Sutro Biopharma, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sutro Biopharma Formerly VC-backed South San Francisco, CA
Chimerix Corporate Backed or Acquired Durham, NC
You’re viewing 2 of 2 competitors. Get the full list »

FLAG Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FLAG Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
U.S. Department of Health and Human Services Government
To view FLAG Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

FLAG Therapeutics FAQs

  • When was FLAG Therapeutics founded?

    FLAG Therapeutics was founded in 2013.

  • Where is FLAG Therapeutics headquartered?

    FLAG Therapeutics is headquartered in Raleigh, NC.

  • What is the size of FLAG Therapeutics?

    FLAG Therapeutics has 5 total employees.

  • What industry is FLAG Therapeutics in?

    FLAG Therapeutics’s primary industry is Drug Discovery.

  • Is FLAG Therapeutics a private or public company?

    FLAG Therapeutics is a Private company.

  • What is FLAG Therapeutics’s current revenue?

    The current revenue for FLAG Therapeutics is .

  • How much funding has FLAG Therapeutics raised over time?

    FLAG Therapeutics has raised $4.05M.

  • Who are FLAG Therapeutics’s investors?

    U.S. Department of Health and Human Services has invested in FLAG Therapeutics.

  • Who are FLAG Therapeutics’s competitors?

    Sutro Biopharma and Chimerix are competitors of FLAG Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »